A pilot study of Positron Emission Tomography (PET) scanning with 89Zr-DFO-Atezolizumab in patients receiving pembrolizumab for non-small cell lung cancer
We use cookies to keep your session secure, remember your preferences, and analyse site traffic with Google Analytics.
By continuing to use GrantFunds you agree to our
Privacy Policy
and
Terms of Use.